Consistently with these in vitro results, our in vivo study with an orthotopic, syngenetic GL26 glioma model indicated a remarked increase in IL-6 expression by tumor-associated ECs, in comparison to normal brain ECs (Fig. 3d). The gene discussed is IL6; the disease is neoplasm.